A new prostate cancer study that may change treatment in the future | Dr Dilanka De Silva
Who this is for High-risk localised prostate cancer means prostate cancer has not spread to distant organs, but still has
AMPLITUDE: Should treatment be intensified from the beginning for BRCA2-positive metastatic prostate cancer? | Dr Dilanka De Silva
Who this is for Men who have been newly diagnosed with metastatic prostate cancer, particularly those found to carry a
Why two men with the same metastatic prostate cancer can have very different outcomes? | Dr Dilanka De Silva
Who this is for Metastatic prostate cancer does not behave the same way in every man. This article is for
Your CT scan was normal. Why did the PSMA PET find cancer? | Dr Dilanka De Silva
Who this is for PSMA PET prostate cancer imaging can sometimes find cancer that CT scans and bone scans miss.
Prostate cancer with lymph node involvement: why some men may benefit from more treatment at the beginning | Dr Dilanka De Silva
Who this is for Lymph node-positive prostate cancer means prostate cancer has reached nearby lymph nodes, but this does not
Prostate cancer treatment in Melbourne: the 3 biggest changes over the last decade | Dr Dilanka De Silva
Who this is for Prostate cancer treatment in Melbourne has changed significantly over the last decade. If you have recently
Is One Immunotherapy Drug Enough for MSI-High Metastatic Colon Cancer, or Is Two Better? | Dr Dilanka De Silva
Who this is for “I have been diagnosed with metastatic colon cancer and my doctor told me that my cancer
Lynch Syndrome and Colon Cancer: Could Immunotherapy Change Everything? | Dr Dilanka De Silva
Who This Is For Lynch syndrome colon cancer is different from many other bowel cancers because it may respond strongly
You’ve been diagnosed with colon cancer or rectal cancer. Will immunotherapy work for me? | Dr Dilanka De Silva
Who This Is For MSI-high colorectal cancer immunotherapy is becoming an important topic for patients diagnosed with colon cancer or
ATOMIC Study: Could Immunotherapy Reduce Colon Cancer From Returning? | Dr Dilanka De Silva
Who this is for MSI-high colon cancer immunotherapy is becoming an important topic for patients with stage III colon cancer